Citation Impact
Citing Papers
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 Standout
Parkinson disease
2017 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Clinically Important Drug Interactions with Anticoagulants
1996
Parkinson's disease
2021 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Nanoparticles in Medicine: Therapeutic Applications and Developments
2007 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Oral Anticoagulant Therapy
2012 Standout
Gastric retention properties of superporous hydrogel composites
2000
Albumin–drug interaction and its clinical implication
2013 Standout
Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT).
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Mechanisms of nitrate tolerance
1994
Parkinson's disease
2015 Standout
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses
2012
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
2006
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate
2012
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Non-motor features of Parkinson disease
2017 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation
2009
Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats
2016 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
The Silicon–Hydrogen Exchange Reaction: A Catalytic σ-Bond Metathesis Approach to the Enantioselective Synthesis of Enol Silanes
2020 StandoutNobel
Pharmacological Treatment of Parkinson Disease
2014
Clinical Perspectives on Lacosamide
2008
Phosphine Organocatalysis
2018 Standout
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
2015
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
MOLECULAR MECHANISMS OF PROSTAGLANDIN TRANSPORT
1998
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
A carbohydrate approach for the formal total synthesis of the prostacyclin analogue (16S)-iloprost
2012
The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds
1999
Synthesis of Nitrogen‐Containing Heterocycles and Cyclopentenone Derivatives via Phosphine‐Catalyzed Michael Addition/Intramolecular Wittig Reaction
2017
Major Facilitator Superfamily
1998 Standout
Steady‐State Pharmacodynamics and Pharmacokinetics of Warfarin in the Presence and Absence of Telmisartan in Healthy Male Volunteers
2000
Biomedical applications of hydrogels: A review of patents and commercial products
2014 Standout
Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS
2003 Standout
The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice
2014
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Willi Cawello being referenced
An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome
2015
Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
2008
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects
1994
Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies
2012
The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate
1994
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
2009
Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine
2008
Investigation of the Gastrointestinal Transit and In Vivo Drug Release of Isosorbide-5-Nitrate Pellets
1987
Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin
1993
Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.
1995
Drug metabolism and pharmacokinetics
2009
Pharmacokinetics of isosorbide-5-nitrate during haemodialysis and peritoneal dialysis
1987
196 LOW POTENTIAL FOR DRUG—DRUG‐INTERACTION OF LACOSAMIDE
2007